# Final Recommendation — Team3 AEGIS-PHARMA

| Field | Entry |
|---|---|
| Date | 2026-08-07 |
| Framing | `hypothesis` |
| Demo | **conditional-go** |
| Production / validated DSS | **no-go** |

## Recommendation (one paragraph)

**Approve a controlled demo of the fail-closed AEGIS Evidence Assist PoC; do not authorize production GxP decision support, LLM-on-assessed operation, or any write/execution plane.** Fund P0 measurement (cycle-time, entitlement/document SoT policy, review hours) and an AC-052 continuity drill before any path to decision-ready framing or production reassessment.

## Why

1. Hard controls are demonstrated and tested (AuthZ, disposition, reservation, AI-disabled, evaluate).  
2. Business ROI / −14% claims would invent facts — baselines Missing.  
3. Decision rights require humans outside the system for certification, final PV, and allocation.  
4. Assurance case supports demo claim C0, not production claim C0′.

## Immediate next actions

| When | Action |
|---|---|
| Now | Run defence demos; record sponsor S1–S7 |
| 0–30d | Freeze hypothesis narrative; start P0 sample plan |
| 31–90d | Drill, AuthZ expand, TEVV bar — per Phase 7 roadmap |

## Explicit non-recommendations

- Do not treat CLI PoC as validated DSS.  
- Do not enable fuzzy auto-merge or LLM assessed without ADR gates.  
- Do not connect MES/WMS/Safety write adapters.  
- Do not claim EU AI Act / ISO 42001 / GDPR compliance from these artefacts.

## Sign-off pointers

| Artefact | Path |
|---|---|
| Elevator pitch | `30_ELEVATOR_PITCH.md` |
| Failure demos | `failure_demo_results.csv` / `FAILURE_DEMOS.md` |
| Assurance case | `../05_assurance_evaluation_ops/21_ASSURANCE_CASE.md` |
| Prod readiness | `../07_operating_model_transfer/28_PRODUCTION_READINESS.md` |
| Decision log | `../00_preflight/00_ASSUMPTIONS_DECISION_LOG.md` |
